3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials. (June 2020)

Record Type:: Journal Article
Title:: 3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials. (June 2020)
Main Title:: 3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials
Authors:: Sisay, Mekonnen
Abstract:
Is Part Of:: Pharmacological research. Volume 156(2020)
Journal:: Pharmacological research
Issue:: Volume 156(2020)
Issue Display:: Volume 156, Issue 2020 (2020)
Year:: 2020
Volume:: 156
Issue:: 2020
Issue Sort Value:: 2020-0156-2020-0000
Page Start:
Page End:
Publication Date:: 2020-06
Subjects:: Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105
Journal URLs:: http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.phrs.2020.104779 ↗
Languages:: English
ISSNs:: 1043-6618
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13508.xml